Supplementary Figure S5 from Targeting CDK7 Enhances the Antitumor Efficacy of Enzalutamide in Androgen Receptor–Positive Triple-Negative Breast Cancer by Inhibiting c-MYC–mediated Tumorigenesis
Open Access
- 4 June 2025
- other
- Published by American Association for Cancer Research (AACR)